Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $761000.0.

  • Anika Therapeutics' Other Non-Current Liabilities fell 558.31% to $761000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $761000.0, marking a year-over-year decrease of 558.31%. This contributed to the annual value of $772000.0 for FY2024, which is 9108.91% up from last year.
  • According to the latest figures from Q3 2025, Anika Therapeutics' Other Non-Current Liabilities is $761000.0, which was down 558.31% from $756000.0 recorded in Q2 2025.
  • Anika Therapeutics' Other Non-Current Liabilities' 5-year high stood at $16.9 million during Q2 2021, with a 5-year trough of $398000.0 in Q4 2022.
  • Its 5-year average for Other Non-Current Liabilities is $1.8 million, with a median of $684000.0 in 2022.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 9652.66% in 2022, then soared by 10150.0% in 2024.
  • Quarter analysis of 5 years shows Anika Therapeutics' Other Non-Current Liabilities stood at $1.3 million in 2021, then tumbled by 68.36% to $398000.0 in 2022, then increased by 1.51% to $404000.0 in 2023, then skyrocketed by 91.09% to $772000.0 in 2024, then fell by 1.42% to $761000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $761000.0 for Q3 2025, versus $756000.0 for Q2 2025 and $744000.0 for Q1 2025.